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Human cytomegalovirus (HCMV) exhibits surprisingly high genomic
diversity during natural infection although little is known about
the limits or patterns of HCMV diversity among humans. To address
this deficiency, we analyzed genomic diversity among congenitally
infected infants. We show that there is an upper limit to HCMV
genomic diversity in these patient samples, with ∼25% of the ge-
nome being devoid of polymorphisms. These low diversity regions
were distributed across 26 loci that were preferentially located in
DNA-processing genes. Furthermore, by developing, to our knowl-
edge, the first genome-wide mutation and recombination rate maps
for HCMV, we show that genomic diversity is positively correlated
with these two rates. In contrast, median levels of viral genomic di-
versity did not vary between putatively single or mixed strain infec-
tions. We also provide evidence that HCMV populations isolated from
vascular compartments of hosts from different continents are genet-
ically similar and that polymorphisms in glycoproteins and regulatory
proteins are enriched in these viral populations. This analysis provides
the most highly detailed map of HCMV genomic diversity in human
hosts to date and informs our understanding of the distribution of
HCMV genomic diversity within human hosts.
human cytomegalovirus | HCMV | congenital CMV | virology | evolution
Human cytomegalovirus (HCMV) is a pathogen of criticalimportance to human health. HCMV is the leading cause of
birth defects related to an infectious agent (1, 2) and a primary
cause of solid organ transplant failure (3). Prevention and clin-
ical interventions for HCMV disease are limited by the absence
of an effective vaccine, as well as resistance to antiviral drugs (4)
and therapeutic neutralizing antibodies (5).
Recently, it has been proposed that HCMV disease and patho-
genesis may be related to the genetic diversity of the virus (6), which
is exceptionally high both within and between hosts (7–11). The
viral interhost diversity was first described through restriction
fragment length polymorphism analysis (12) and was subsequently
confirmed with targeted gene and genome-wide sequencing (7, 8,
13). In a similar manner, HCMV intrahost diversity has been de-
scribed using genetic and genomic sequencing (10, 11, 14–17) and
has been shown to be comparable with diversity observed in RNA
viruses, the benchmark of variable populations (10). HCMV thus
exists within hosts as a heterogeneous collection of diverse but re-
lated genomes, herein termed a population, rather than a single
sequence. The high levels of intrahost genetic diversity in HCMV
infections are seen across a range of human hosts, from healthy
adults (14) and children (18) to congenitally infected infants (19),
transplant recipients (17), and AIDS patients (20). The clinical
importance of HCMV genetic diversity is still debated (21), but
increasing evidence suggests a correlation with HCMV pathogen-
esis. For example, higher viral loads are associated with diverse
HCMV infections (22, 23), as is disease progression for both
HCMV disease (15) and AIDS patients (24). HCMV is capable of
infecting a wide range of host organs and cell types, and in vivo
infection leads to widespread viral dissemination. Multiple reports
show that HCMV genotypes and total levels of diversity differ be-
tween host organs, a phenomenon referred to as compartmentali-
zation (11, 19, 25, 26). More recently, whole genome sequencing
showed that HCMV populations sampled from different compart-
ments can be as divergent as sequences sampled from unrelated
hosts (11). Tentative links between diversity in viral glycoproteins
and dissemination are beginning to form. For example, genetic
variation in the gO locus alters the ratio of the gH/gL/UL128-131
and gH/gL/gO complexes and is proposed to influence endothelial
and fibroblast cell tropism and dissemination (27). Likewise, various
gB (UL55) genotypes are preferentially associated with host com-
partments, suggesting a role for gB variation in tropism (28). Lastly,
positive selection targets glycoproteins during viral dissemination
from plasma to urine (11), suggesting a link between variable viral
genetics and fitness in different host compartments.
This previous work (8, 10) has demonstrated that HCMV is
genetically diverse within and among human hosts. It has been
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speculated that this genetic diversity may contribute to patho-
genesis, possibly due to effects on immune evasion or dissemination
(6). However, HCMV diversity has not been fully characterized,
thereby hindering more complex analyses of the possible relation-
ship between viral diversity and disease. For example, it is not clear
whether the diversity is evenly distributed across the genome or
which factors alter its genome-wide patterns. Moreover, analysis of
the spatiotemporal distribution of HCMV diversity has been used
to study the contribution of neutral and selective evolutionary
mechanisms affecting HCMV populations during dissemination
(11), but the analysis requires study across a larger patient cohort.
To begin to address these issues, we have initiated, to our
knowledge, the first large-scale analysis of HCMV intra- and inter-
host genomic diversity across a range of unrelated and geo-
graphically disperse human hosts. We here focus on congenitally
infected infants because HCMV genomic diversity has been quan-
titatively described in these hosts. Through our analyses, we confirm
the high levels of intra- and interhost genomic diversity of HCMV
but also show that roughly one-quarter of the HCMV genome is
monomorphic and seems selectively constrained. Furthermore, we
identify hot and cold spots of diversity, which may partially be
explained by selection on known protein function, and variations in
genome-wide mutation and recombination rates. Lastly, we provide
further evidence of the differences in diversity between host com-
partments, showing that plasma populations among unrelated and
geographically separated hosts are genetically alike and that poly-
morphisms within glycoproteins are enriched in these populations.
These analyses provide the most detailed description to date of the
patterns and limits of HCMV genomic diversity in human hosts.
Results
Estimation of Overall Diversity and Conservation of the HCMV
Genome. We performed an analysis of 48 HCMV-positive sam-
ples, 30 of which have not been described previously, collected
from 18 patients (Table S1). Forty-seven of the 48 samples were
collected from infants with congenital CMV infection, and 1
sample was collected from an adult with glioblastoma multi-
forme (GBM). The GBM sample has been described previously
(16) and was included to serve as an outlier to compare with the
remaining samples. The dataset encompasses over 41 gigabases
of HCMV sequence (Table 1). The median viral genomic cov-
erage was 89.5%, and the median sequencing depth was 2,175
(Table 1). In total, ∼860,000 single nucleotide polymorphisms
(SNPs) were identified, and ∼154,000 sites across the HCMV
genome were polymorphic in one or more samples in the dataset.
When plotted as a function of samples or patients analyzed, the
number of polymorphic sites seems to be asymptotic. Saturation
curves were fitted to these data (r2 = 0.9951 for Fig. 1A, and r2 =
0.9996 for Fig. 1B), and a parameter of this curve Lmax, repre-
senting the theoretical maximal number of (nonerroneous)
polymorphic sites in the genome, was defined. With these data,
Lmax was calculated to be 161,646 (95% confidence interval,
159,019–164,273) for samples (Fig. 1A) and 155,874 (95% con-
fidence interval, 154,101–157,647) for patients (Fig. 1B). These
data suggest that a significant fraction of the HCMV genome is
conserved across patients.
Genome-Wide Patterns of Diversity. Next, the pattern of diversity
in the HCMV genome was analyzed. To determine how the
polymorphisms were distributed across the genome, the aver-
age number of SNPs per nucleotide position (i.e., SNP density)
was calculated in 100-base pair (bp) sliding windows across the
genome (Fig. 2, inner gray circle), and the number of non-
synonymous SNPs was calculated for each ORF (Fig. 2, middle
gray circle). Lastly, a statistical test described previously (29)
was used to identify regions with significantly reduced diversity
compared with the remainder of the genome (Fig. 2, outer gray
circle). For each region, q values, or false discovery rate cor-
rected P values, were calculated to test the significance of re-
gions with lower than expected diversity. The q values were
plotted as –log10 values, such that increasing values signify
greater significance. In this analysis, a strong correlation was
identified between SNP density and sample coverage when the
number of samples was <24 although this relationship was largely
absent when the number of samples with sequence coverage was ≥24
(Fig. S1). Therefore, this analysis was limited only to sites that were
sequenced in ≥24 samples (n = 214,369, ∼91% of the genome).
SNP density and nonsynonymous SNP density were strongly
correlated across the genome, and variations in SNP density
were observed. For example, the UL132 gene, a glycoprotein
previously shown to be diverse in infants (30), and US2 gene, a
well characterized immune evasion gene (31), harbored a high
concentration of SNPs. Regions of statistically significant low SNP
density were identified in 26 regions, encompassing ∼14 kilobases
(kb) (Fig. 2, outer gray circle). These regions were enriched in
herpesvirus core genes: that is, genes conserved across herpesvi-
ruses (Fig. S2). The low SNP density regions were also more fre-
quently located in genes encoding DNA replication and processing
proteins, as well as those encoding capsid, tegument, and regulatory
Table 1. Summary of HCMV sequencing data
Unique patients 18
No. of samples 48
No. of bases sequenced 4.1 x 1010
Median genome coverage 89.5%
Average depth 2,175
Total SNPs 859,441
Total unique SNPs 214,718
Total unique sites 153,975
Fig. 1. Limits of HCMV diversity. Plotted is the number of polymorphic sites
identified as a function of the number of samples (A) or patients (B). Saturation




where Tsites is the total number of polymorphic sites, S is the number of samples
or patients, Lmax is the maximum number of polymorphic sites, Ks is the number
of samples at which half the polymorphic sites have been discovered, and E is the
error rate per sample. Lmax for the two plots indicate the theoretical maximum
number of polymorphic sites present in HCMV samples from congenital in-
fections. The value for Lmax was calculated as 161,646 (95% confidence interval,
159,019–164,273) in A and 155,874 (95% confidence interval, 154,101–157,647)
in B. For A, all samples (n = 48) are included; for B, only one representative
sample from each patient (n = 18) was used.















proteins (Fig. 3A). In contrast, genes encoding envelope, glyco-
proteins, and immune evasion genes exhibited high SNP densities.
Thus, the data suggest that variation in genome-wide diversity
correlates with protein function.
Correlation of Diversity with Mutation and Recombination Rates.
Neutral factors, such as variation in mutation and recombina-
tion rates, likely contribute to variation in genome-wide diversity.
Mutation rates have been shown to vary across the genome of a
wide range of species (32–35). No genome-wide mutation rate
data were available for HCMV; thus, the patient sample data
collected here were used to estimate these rates. De novo mu-
tations were identified in longitudinal patient samples, and, as
with previous mutation accumulation analyses (34, 36), mutation
rates were calculated in 500-bp windows. The genome-wide av-
erage was 2 × 10−7 mutations per base pair per generation. This
estimate was ∼10-fold higher than previous in vitro estimates for
herpes simplex virus type 1 (37, 38) but was comparable to in
vivo estimates for murine cytomegalovirus (39). Further, there
was a weak (Pearson’s correlation coefficient r = 0.28, r2 = 0.083)
but highly significant positive correlation between estimated
mutation rate and SNP density (Fig. 3B).
Recombination rates, like mutation rates, can also vary across the
genome (40, 41) and have previously been shown to correlate with
the level of intraspecies diversity (42). Although mutation rates can
directly alter levels of diversity, recombination rates likely correlate
with diversity because of a coupling with either positive or purifying
selection, which reduces diversity in a region of the genome that is
proportional to local recombination rates (43–45). No genome-wide
recombination map was available for HCMV. To address this de-
ficiency, the population sequence data from the current study was
analyzed using an approach described previously (40), and re-
combination rates were estimated in 500-bp windows across the
genome. The genome-wide average of 2Ner/kb, where Ne is the
effective population size and r is the per generation recombination
rate, was 2.01. Using previous estimates of ∼1,000 for the effective
population size (Ne) of HCMV (11) resulted in a recombination
rate of ∼0.23 cross-over events per genome per generation or 1
cross-over per genome every 4.2 generations. The highest re-
combination rates were detected near the oriLyt region and the UL/b′
and internal repeat short (IRS) junction, and the lowest rates were
located in theUL86ORF. Similar to mutation rate, a weak but highly
significant correlation was observed between recombination rates and
SNP density (Pearson’s correlation coefficient r = 0.28, r2 = 0.077)
(Fig. 3C). In total, the data presented in Fig. 3 suggest that variation
in genome-wide diversity is correlated with protein function, as well
as mutation and recombination rates.
Compartmental Distribution of HCMV Diversity. Our studies exam-
ined the limits and patterns of diversity observed in HCMV sampled
from a diverse array of host compartments, including urine, plasma,
cord blood, saliva, and a tumor. Previous work has shown that
HCMV genetic diversity can vary across host compartments in a
phenomenon known as compartmentalization (25, 26). To determine
whether genomic diversity segregates according to host compartment,
the dataset of the current study was subjected to discriminant analysis
of principal components (DAPC) (46). This represents a three-phase
approach, with the optimal number of clusters defined first, followed
by a principal components analysis (PCA) and then discriminant
analysis (DA) of the principal components. DA is designed to assign
cluster or group membership by maximizing between-group variation
and minimizing within-group variation, but requires a small number
of uncorrelated variables, a requirement that is violated when
studying large datasets of SNPs. PCA can transform a large dataset
into a reduced number of uncorrelated variables (i.e., principal
components). Thus, by combining PCA and DA, DAPC capitalizes
on the strengths of two multivariate analyses to study large datasets
and uncover underlying population structure.
The optimal number of clusters was first inferred using kmeans
analysis of the genome-wide HCMV SNP frequency data from all
patients and evaluation using Bayesian information criterion (BIC)
(47). Clusters in this context are analogous to viral clades identified
through phylogenetic analysis of consensus sequences, with a pri-
mary difference that the clustering analysis was performed on all
SNPs, including consensus and those at lower frequencies. This
analysis revealed that HCMV populations were best characterized
with five clusters (Fig. 4A), a conclusion that was further supported
by an independent cluster analysis (Fig. S3). The data were then
transformed with PCA, and the principal components were analyzed
with DA. The outputs fromDA were discriminant functions, and the
first two discriminant functions were plotted in Fig. 4B. Similarity
between clusters and HCMV populations can be inferred from
distance between groupings on the scatterplot (Fig. 4B) (47). Three
clusters (clusters 3–5) were most alike whereas two clusters (clusters
1 and 2) showed increased genetic distance to the other groups (Fig.
4B). Cluster 4 was most closely related to all other clusters. All
samples showed a high probability of belonging only to a single
cluster (membership probabilities of Fig. 4C), reducing the ambiguity
of the analysis and suggesting that most SNPs supported the mem-
bership assignment. Cluster membership was then analyzed by pa-
tient compartments (Fig. 4C) to test for a potential relationship
between viral genetics and host compartments. The six saliva sam-
ples contained representatives of three clusters, and urine samples
represented all five clusters. In contrast, all eight plasma samples
contained members from a single cluster, specifically cluster 4. This
cluster, however, was not exclusively represented by plasma samples
because urine samples were also present in the grouping as was the
adult GBM sample, originally chosen to serve as an outlier. The
DAPC analysis revealed that the GBM population was very similar
to plasma populations, such as those sampled from patients M103
and B103. In total, the data suggested that plasma populations may
Fig. 2. Diversity across the HCMV genome. Shown is a circular plot of the
HCMV genome, with green and orange shading denoting the unique long
(UL) and unique short (US) regions, respectively. Within the inner circle,
white indicates noncoding regions and black marks all ORFs. Plotted in
gray concentric circles, from the center to the outer regions, are SNP
density, nonsynonymous SNP density, and –log(q values) from a statistical
test of low SNP density. Only significant q values (≤0.01) are plotted. The
outer red circle highlights regions with sufficient coverage to accurately
quantify diversity (≥24 samples) (Fig. S1).
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be more alike than populations sampled from saliva or urine com-
partments. Intragroup comparisons were performed to test this
model. For example, plasma samples were compared with all other
plasma samples using percent differences of consensus sequences
(Fig. 4D) and FST as metrics of similarity (Fig. 4E). FST is a statistic
evaluating the frequency of all alleles present in two populations and
ranges from 0 to 1, with 0 meaning all diversity is shared between
populations and 1 meaning no diversity is shared between pop-
ulations. The intragroup comparisons showed that plasma pop-
ulations are more similar than the intragroup comparisons of saliva
or urine. Further, urine populations tended to be highly dissimilar,
consistent with the DAPC analysis. In total, these data suggest that
HCMV populations sampled from plasma compartments are more
genetically related, and perhaps more strongly constrained, than
those from the saliva or urine compartments.
Plasma-Associated Polymorphisms.Given the relatedness of plasma-
sampled populations, it was determined whether a subset of poly-
morphisms was enriched within these populations. It was assumed
that the polymorphisms were binomially distributed across the
various samples and were not preferentially associated with any host
compartment. A binomial test of significance with a false discovery
rate correction was then used to test whether polymorphisms were
enriched in plasma populations (Fig. 5A). In total, 655 poly-
morphisms were significantly associated with plasma populations.
These polymorphisms (Fig. 5B), and specifically the nonsynonymous
polymorphisms (Fig. 5C), were more common in ORFs encoding
glycoproteins and regulatory proteins. The polymorphisms with the
highest statistical significance were present in the ORFs encoding
the glycoproteins gB (UL55), gO (UL74), gN (UL73), and gH
(UL75). In addition, the plasma-enriched SNPs were common in
noncore ORFs: i.e., the ORFs that are not conserved across human
herpesviruses (Fig. S4), suggesting that these SNPs affect phenotypes
most associated with HCMV.
Analysis of Mixed Infections. Many samples in this study were col-
lected either across time and/or across compartments from the
same patient. These samples were analyzed in an attempt to un-
derstand whether the observed patterns of diversity result from
single or multiple strain infections. The hypothesis was that all
samples collected from single strain infections would be genetically
similar whereas those samples collected from mixed infections or
reinfections could be more divergent because the relative pro-
portion of mixed strains could change over time or across com-
partments within a host. Longitudinal or compartmental samples
were collected from 12 patients, and genetic relatedness of the
samples was visually analyzed with principal components analysis
(PCA) (Fig. S5). PCA, as opposed to DAPC, was used for visual-
ization because DAPC was designed to minimize within cluster or
clade variation, which may decrease the ability to identify two
strains from the same clade. Using the visual analysis, putatively
single strain infections were exemplified by samples from patient
HG1, in which five urine samples overlap on the PCA plot, and
patient 1254, in which urine and saliva samples collected over 2 y
were nearly identical (Fig. S5). In contrast, a later time point saliva
sample collected from patient 1587 was highly differentiated from
an earlier time point saliva sample, as well as urine samples col-
lected at nearly the same time (Fig. S5), a pattern expected in mixed
infections or reinfections. Samples collected from patients 1587,
B103, M74, and U45 were consistent with mixed infections or re-
infections. Consensus sequences from the samples were compared,
with calculation of the percent differences as a measure of di-
vergence. The percent differences from putatively mixed strain in-
fections were similar to values obtained from unique strains (10)
(Fig. S6) although the divergence of samples from patient U45 was
at intermediate levels. Further analysis showed that the genome-
wide intrahost diversity of samples collected from putatively single
or mixed strain infections was indistinguishable and that the ge-
nome-wide patterns in diversity were highly similar (Fig. S7). Thus,
the data suggest that mixed strain infections or reinfections occur in
Fig. 3. Diversity by ORF function andmutation and recombination rate. Plotted
are the relationships between observed diversity in the HCMV genome and ORF
protein function, mutation rate, and recombination rate. (A) Low SNP density
regions of the genome were identified and were assigned to all ORFs of the
HCMV genome. The number of significant low density windows per ORF was
plotted as a function of protein function, and P value represents results from a
Kruskal–Wallis analysis. Red bars mark the group mean, and black bars mark the
SEM. (B) Mutation rates were calculated in 500-bp windows by identifying de
novo mutations in time-sampled data. Genome-wide SNP densities were then
plotted as a function of local mutation rates. A linear regression analysis (red
line) was applied to the data and was significantly nonzero (P < 0.0001). The
Pearson’s correlation for the data was 0.29 (r2 = 0.083). (C) As in B, SNP density
was plotted as a function of recombination rates, with a linear regression shown
as a red line. The regression analysis was significantly nonzero (P < 0.0001), and
the Pearson’s correlation was 0.28 (r2 = 0.077).















at least a third of congenitally infected infants although the ge-
nome-wide viral intrahost diversity is not greatly affected by the
differences in infection status.
Discussion
Increasing evidence has shown that HCMV is a genetically di-
verse virus when analyzed between and within human hosts.
Here, we performed a large-scale analysis of 48 HCMV pop-
ulations sampled from 17 infants with congenital CMV infection
and 1 adult with glioblastoma multiforme and identified variable
and highly conserved regions across the viral genome. We have
shown that the most conserved regions of the genome are lo-
cated in genes encoding DNA-processing enzymes, capsid, and
tegument proteins. We also demonstrate how the genomic di-
versity is distributed across three host compartments, showing
that plasma populations are genetically constrained and enriched
Fig. 4. Cluster analysis of HCMV populations. Discriminant analysis of principal components (DAPC) was performed on SNP frequency data from 48 HCMV
populations. In this analysis, the optimal number of clusters or groupings was first inferred, followed by transformation of the data with principal components
analysis. Lastly, a discriminant analysis of the principal components was performed, using the number of clusters inferred in the first step, to minimize within-
cluster variance, maximize between-cluster variance, and reveal underlying population structure and genetic relatedness of samples. (A) Cluster analysis was
performed with increasing numbers of clusters. A Bayesian information criterion (BIC) was implemented to identify the cluster number that minimizes within-
cluster variance while avoiding model overfitting. Five clusters yielded the lowest BIC score and were used in subsequent analyses. These data suggest that
there are at least five clusters or clades within the analyzed dataset. (B) Discriminant analysis, the final step of DAPC, was used to generate discriminant
functions that “discriminate” between clusters and can be plotted to infer genetic relatedness and population structure. A scatter plot of the first two
discriminant functions was generated to analyze HCMV populations. Distance on the plot is proportional to genetic distance between clusters, and thus
clusters 3, 4, and 5 are alike whereas clusters 1 and 2 are more distantly related. The eigenvalues (Inset) show the amount of variance accounted for by the
four retained discriminant functions, showing that the first two functions explain the majority of variance in the data. (C) Cluster membership probabilities of
all samples used in this study, grouped by host compartment. All samples were assigned to clusters with 100% probability, yielding high confidence in the
assignments and suggesting that many SNPs support the presented results. Saliva samples were predominantly represented in cluster 5 although members
from cluster 2 and 3 were also present. Urine samples contained members of all five clusters. Plasma samples were exclusively grouped into cluster 4. (D and E)
Samples from the same host compartment were grouped, and pairwise comparisons to all other samples from the same host compartment (i.e., intragroup
comparisons) were performed. The percent difference of consensus sequences (D) or FST (E) from the pairwise comparisons are plotted. HCMV populations
from plasma samples tended to be more alike than HCMV collected from the saliva or urine host compartments.
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for SNPs within glycoproteins and regulatory proteins. Lastly,
analysis of mixed and single strain infections suggest that genome-
wide intrahost diversity is similar between the types of infection.
These data have clear implications in our understanding of
HCMV evolution. Polymorphisms were absent in approximately
one-quarter of the HCMV genome, suggesting an upper limit to
HCMV diversity in these patient samples. With Lmax values of
154,101–164,273 reported in Fig. 1, and high coverage sequence
data for 91% of the genome (214,369 bp), ∼23–28% of the genome
is conserved. These values differ from those estimated for other
species. The number of conserved sites in the human genome is
∼8% (48), and, in other viruses, the proportion is much higher,
including 66% for HIV (49), 63% for influenza A virus (50), and
78% for rubella virus (51). These trends suggest that the number of
invariant sites is inversely correlated with genome size. An outlier,
however, is hepatitis C virus, which encodes a 9.6-kb genome in
which ∼35% of the genome is conserved although 84% of the 5′
UTR region is conserved (52). A practical application of the limit of
diversity and identification of conserved sites is in rational design
and evaluation of anti-HCMV therapeutics. Currently, antiviral
resistance has been identified for all FDA-approved small molecule
inhibitors of HCMV (4). Additional therapeutics have been de-
veloped, including the terminase inhibitor letermovir and at least
one neutralizing monoclonal antibody against gH. However, re-
sistance against these compounds has been generated in laboratory
experiments (5, 53), reinforcing the need to design therapeutics
with reduced probability of resistance. The current study has
revealed the existence of small, highly conserved, and thus likely
highly constrained, sites across the HCMV genome, thereby high-
lighting potential therapeutic targets. These small regions can form
the basis for future informed therapeutic design.
The data presented here also provide evidence for several
mechanisms that alter the distribution of diversity across the
HCMV genome. The analysis revealed that DNA processing en-
zymes are conserved across patients whereas regulatory proteins
and glycoproteins are variable. This correlation of ORF function
and genetic diversity suggests that selection on protein function
shapes diversity, in agreement with previous analyses of HCMV
interhost diversity at a limited set of loci (54). Other mechanisms,
however, could explain the observed correlation. Variations in
transcription levels are associated with variations in mutation rates
(55, 56) and thus could be a confounding factor in the analysis, as
could alterations of transcriptional kinetics. Relatedly, differences
in histone association (57) and epigenetic silencing (58) alter
transcriptional activity and may be associated with protein function.
Changes in DNA biophysical properties that alter mutation po-
tential, such as secondary structure (59), also cannot be excluded as
possible contributors to the observed pattern.
Furthermore, our analysis demonstrates that neutral mecha-
nisms, such as mutation and recombination rates, can correlate with
genetic diversity, similar to previous observations across a diverse
range of species (42). Indeed, ∼10% of the variance in SNP density
could be explained by variations in these rates. Although the cor-
relation between these rates and diversity does not prove causation,
potential mechanistic relationships between the factors can be
proposed. In particular, the correlation between recombination rate
and diversity likely results from the effects of either background
selection and/or genetic hitchhiking. Background selection is the
removal of neutral diversity linked to deleterious alleles (44), and
hitchhiking is the fixation of neutral alleles linked to beneficial al-
leles (43, 60). Both mechanisms are expected to reduce local vari-
ation around the target of selection, and the size of the region of
reduced variation is inversely proportional to recombination rates.
As recombination rates increase, neutral variation can become
unlinked from selected sites and remain as polymorphisms in the
population. Debate continues on the relative contribution of
background selection and hitchhiking on observed patterns of re-
duced diversity in natural populations (45) although it is likely that
both factors are at play in many organisms (61, 62). Further studies
will be needed to disentangle the roles of background selection,
genetic hitchhiking, and recombination in shaping HCMV genomic
diversity and evolution.
Host factors also may be an important contributor to shaping the
patterns of HCMV in vivo diversity. The fetal/neonatal CMV-specific
immune response may significantly affect the CMV genomic
diversity observed in our study. Longitudinal samples were collected
from young infants with ages ranging from 1 wk to 2.5 y. Prior
reports from our group (63–65) and others (66) have shown that
HCMV-specific CD8+ T-cell responses with similar antigen speci-
ficity, phenotype, and functional profiles as adults are detectable in
infants with congenital CMV infection, even during gestation.
Other studies have shown that infants can generate HIV-specific
CD8+ T-cell responses that exert selective pressure and contribute
to the evolution of viral quasi-species over the first year of life (67).
The fate of HIV escape mutations transmitted from mother to
infant may depend on concordance of the HLA alleles restricting
these MHC class I responses, resulting in persistent mutations and
escape from viral control in infants with shared alleles and reversion
of fitness-cost mutations in those with nonshared alleles (67, 68).
Similar studies are warranted in HCMV to better understand the
role that host immunity has in shaping viral diversity and the po-
tential role of viral diversity in immune evasion and mother-to-
child transmission.
Greater knowledge of the rate of HCMV reinfections is of
significant clinical importance, particularly in regard to the de-
velopment of a vaccine against HCMV (69). The annualized rate of
reinfection in healthy adults is as high as 10% (70), and multiple
strain infections in transplant recipients also seem to be common
(17). In this study, we analyzed the proportion of reinfections or
mixed infections by studying the viral population divergence across
time or compartments, estimating that approximately one-third of
infections were mixed or reinfections. This number is similar to
Fig. 5. Identification of plasma-associated polymorphisms. (A) The significance
of polymorphism enrichment in plasma samples compared with all other sam-
ples was tested assuming a binomial distribution and multiple testing correction.
Plotted are –log(q values) generated from the test as a function of SNP genomic
position. Shown in red are significant SNPs (q value of ≤0.01), and blue are
nonsignificant SNPs. The plasma-enriched SNPs (B) or nonsynonymous SNPs (C)
were then assigned to all ORFs of the HCMV genome and plotted by ORF
function. P values represent results from a Kruskal–Wallis analysis. Polymorphism
rate in B corresponds to plasma-enriched SNPs per 100 bp of coding sequence,
and nonsynonymous polymorphism rate is plasma-enriched nonsynonymous
SNPs per 100 codons.















previous estimates based on genotype data (19) but is likely to be an
underestimate because our analysis requires a change in population
structure that may not occur in stable multiple strain infections. The
genome-wide intrahost diversity in putative mixed infections was
statistically identical to single strain infections, suggesting that in-
fection status does not correlate with viral diversity in neonates and
infants. The same result may not be true in other patient cohorts.
The source of the multiple strains of patients in this study is unknown.
Nonprimary maternal infections are increasingly recognized as im-
portant contributors to HCMV in utero transmission (71), accounting
for up to 75% of HCMV congenital infections in the United States
(72). Future investigation studying the natural history of HCMV in-
fections, including viral population demographics of single and mixed
strain infections, would allow for a much better quantification of the
timing and dynamics of in utero mixed infections.
The estimates of HCMV genome-wide mutation rates presented
here are approximately an order of magnitude higher than those of
a closely related herpesvirus, HSV-1, but comparable with murine
cytomegalovirus (39). It should be noted, however, that the HCMV
estimates may be conservative, given the relatively stringent re-
quirements of calling a de novo mutation, specifically maintaining a
sustained frequency above the limits of detection. There are several
reasons that the rates could be higher than those of HSV-1. Al-
though the HSV and HCMV polymerases are similar at the amino
acid level (73), differences exist throughout the coding sequence.
The functional consequences of these variants have not been
characterized although alterations of fidelity are a possibility. Fur-
thermore, extrinsic or accessory factors can alter polymerase fidelity
(74, 75), and the interaction of HSV and HCMV polymerases with
their cognate accessory proteins, UL42 and UL44, respectively, has
been shown to differ at the molecular level (76) as have the qua-
ternary structures of the accessory proteins (77). Lastly, the role of
host factors, such as proteins of the DNA damage response (78, 79),
in altering mutation rates of viral replication cannot be excluded,
particularly because herpesviruses are potent inducers of host DNA
damage responses (79).
Finally, 655 SNPs, of which 219 were nonsynonymous, have been
identified as being enriched in plasma populations, and these
polymorphisms are primarily localized to the glycoproteins and
regulatory proteins. These findings are in agreement with our
previous results that have identified targets of selection during
plasma-to-urine dissemination, in which glycoproteins were also
enriched (11). The underlying biologic explanations of these pat-
terns could be varied. Cellular tropism is a possible candidate,
particularly because the contribution of HCMV glycoproteins to
cellular tropism is well-established (80–83), and genetic variation in
genes encoding glycoproteins may play a role in altering HCMV
tropism in vivo (27, 28). Thus, it is possible that at least a portion of
the plasma-enriched SNPs identified in the current study alter
HCMV tropism. However, other possible biological mechanisms
cannot be excluded, such as the adaptive immune response shaping
the observed SNP compartmentalization. Tissue-specific differences
in immune responses have evolved to address varied routes of
pathogen transmission, such as via blood or mucosal surfaces (84),
and could also be drivers of viral genetic diversity. With the iden-
tification of these plasma-enriched SNPs in patient samples, future
genetic studies can focus on disentangling these and other possible
biologic mechanisms.
HCMV is an important human pathogen and one for which
prevention strategies and therapeutic interventions are needed.
With the current study, we have begun to understand the patterns
and limits of HCMV genomic diversity and have laid the ground-
work for translating these results into future clinical interventions.
Materials and Methods
Ethics Statement. Subjects B101, B103, M103, MS1, and MS2 were described
previously (11) as were U01, U04, and U33 (10) and G1 (16). The use of
specimens from subjects PL2 and U45 was approved by the University of
Massachusetts Medical School and Baystate Medical Center Institutional
Review Boards. Viruses from subjects 956, 1254, M74, and 1587 were col-
lected during research studies at the University of São Paulo in Ribeirão
Preto, São Paulo, Brazil and were approved by the Institutional Review Board
of the Faculty of Medicine of the University of São Paulo in Ribeirão Preto and the
School of Medicine at the University of Alabama in Birmingham as part of a
National Institute of Child Health and Human Development-supported research
project. The use of stored specimens from Brazilian HCMV-infected infants (sub-
jects 956, 1254, M74 and 1587) was approved by the Research Ethics Committee of
the University Hospital. The samples H5478/H5529 and H1109/H1861/H1875 were
derived from the Epidemiologische Untersuchung zur Erhebung der lnzidenz der
kongenitalen Cytomegalvirus Infektion study, which was approved by the Ethik-
Kommission der Medizinischen Fakultät at the Universitätsklinikum Tübingen.
Informed consent was obtained from subjects’ parents for study of HCMV.
Amplification and Sequencing of HCMV DNA. A previously described set of PCR
primers (10) was designed to amplify the entire HCMV genome from a diverse
collection of patient samples. PCR amplification was performed as described
previously (11). The DNA from all reactions of a single sample was quantified on a
Nanodrop 2000 (Thermo Fisher) and pooled in equimolar proportions. Pooled
DNA was then prepared for sequencing on the Illumina HiSeq2000 as described
previously (11) or for sequencing on the ION proton sequencer (Life Technologies)
using the manufacturer’s standard protocols and reagents. Samples were labeled
with DNA barcodes and aggregated into libraries that generally included four to
six samples. Error controls were produced by whole genome amplification of a
BAC clone of HCMV strain AD169, using the same primers and amplification
protocols as used for patient samples. Error control DNA was then prepared for
high throughput sequencing in a manner identical to the patient samples, and
the barcoded error control DNA was included in sequencing libraries.
Sequence Analysis. Sequence data were analyzed in a manner identical to
previously described methods (10, 11), in which a sample-specific consensus se-
quence was called and variants from the consensus were then inferred. SNP
calling was modified from our previously described method. Polymorphisms
were discarded if basecall quality was <20 or if local sequencing depth was <15.
Polymorphisms were then filtered based on platform- and base-specific error
rates calculated from sequencing an error control (Fig. S8). We then calculated
P values for all polymorphisms, assuming a Poisson distribution of error fre-
quencies. Variants with P values of >0.01 were excluded. When ORFs were
classified by function, the classification of Sylwester et al. (85) was used, except
for the inclusion of latency ORFs, which were classified according to Poole et al.
(86). Classification by ORF conservation, including core, beta-gamma, beta, and
noncore genes, was performed according to the information available from the
National Center for Biotechnology Information for the HCMV reference se-
quence (RefSeq ID no. NC006273.2).
Mutation and Recombination Rate Estimation. Mutation rates were estimated
from putatively de novo mutations accumulated during the time of sampling. In
this study, five patients provided longitudinal samples collected at three or more
timepoints. Thesepatients are identifiedasMS1,MS2,HG1, 1587, and1254. These
longitudinal samples were collected from the urine. Putative de novo mutations
were identified as newly arising SNPs that were absent in earlier samples and
present in all later samples. For example, five samples were collected from patient
1254. A de novo mutation was called if an SNP was not present in the first two
samples and then identified in all of the three later samples. Mutation rates were
then calculatedasmutations pergenerationperbase bydividing thegenome into
500-bp windows and using previously described estimates of HCMV in vivo
generation time (87). Recombination rates were estimated using the population
sequence data from the current study and were analyzed with the interval al-
gorithm provided in the LDhat program (40). The algorithm implements a
Bayesian reversible jump Markov chain Monte Carlo approach. Recombination
rate estimates were calculated in 500-bp windows across the genome, and re-
gions with sample coverage <24 (Fig. S1) were excluded from further analysis.
Discriminant Analysis of Principal Components. DAPC (46), as implemented in
the adegenet R software package (47), was applied to polymorphism data in this
study. This approach occurs in three phases, with the optimal number of clusters
defined first, followed by a principal components analysis (PCA) and then dis-
criminant analysis (DA) of the principal components. PCA transforms a large
dataset, such as SNP data, into a reduced number of uncorrelated variables,
which are subjected to DA to assign cluster or groupmembership by maximizing
between-group variation and minimizing within-group variation. The input
for the DAPC analysis was a matrix in which the rows were the patient samples
and the columns were the analyzed SNPs. The elements of the matrix were
the frequencies of each SNP in each patient sample. To account for variation in
E4126 | www.pnas.org/cgi/doi/10.1073/pnas.1501880112 Renzette et al.
sequencing coverage across samples or possible erroneous SNP calls, only
polymorphic sites that were covered in >90% of samples were included, and
all singleton SNPs (i.e., SNPs occurring in only one sample) were excluded. This
filtering resulted in a dataset consisting of 4,060 SNPs. The kmeans algorithm
was implemented with the find.clusters command of the adegenet R software
package (88), with a maximum number of clusters equal to 47 and 10,000 it-
erations of the algorithm. Optimal cluster values were evaluated using the
Bayesian information criterion (BIC), and results for cluster values of ≤10 are
presented for clarity (Fig. 5A). The dapc command with a cluster value of 5 was
then applied to transform the data with PCA followed by DA to calculate
cluster membership and membership probabilities.
The gap statistic was also used to verify the results obtained with the
kmeans analysis. The gap statistic measures the difference, or gap, be-
tween the within-cluster variance compared with the expected variance
given a null distribution (89). This statistic was calculated for cluster values
ranging from 1 to 10 (Fig. S3) using the cluster R software package (90) and
1,000 bootstrap replicates. The maximum value for the gap statistic, cor-
responding to the number of clusters that best explain the data, was
obtained at five clusters, in agreement with the results from the kmeans
analysis. It is noted that a larger numbers of clusters (for example six
clusters) were also good fits for the data. This result likely reflects the fact
that HCMV within and among humans are not wholly isolated, panmictic
populations, as assumed by the clustering algorithms, because migration
within hosts (11) and transmission between hosts (70) occurs at an
appreciable rate.
Intragroup comparisons were performed as described in Results, Compart-
mental Distribution of HCMV Diversity. Only one sample from each patient was
included and was chosen based on the highest genomic coverage. FST was per-
formed using a previously described method (91). For these analyses, the am-
niotic fluid sample (H1109) was included in the urine grouping because this
sample was collected later in pregnancy when fetal urine contributes signifi-
cantly to the production of amniotic fluid (92), and cord blood samples were
grouped with plasma samples. The GBM sample was excluded from these
comparisons.
Statistical Analysis. SNP density was analyzed using the method described
previously (29) to identify and calculate q values for low density regions. SNP
density was analyzed in a sliding window analysis, with 100-bp window sizes
and 25-bp step sizes. A background distribution of densities was calculated
by resampling from the data 10,000 times, and P values were calculated
from this distribution. A Benjamini–Hochberg false discovery rate was
ascertained from the data to calculate q values. Significance of SNP enrich-
ment in plasma samples was evaluated assuming a binomial distribution
of SNP associations, and a multiple testing correction was applied with a
Benjamini–Hochberg false discovery rate procedure. Only sites that were
covered in >90% of samples were included in the analysis.
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